Cover Image
Market Research Report

Global Cell-based Assays Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 913485
Published Content info 324 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Cell-based Assays Market: Industry Trends and Forecast to 2026
Published: October 1, 2019 Content info: 324 Pages
Description

Global cell based assays market is projected to register a substantial CAGR of 8.7% in the forecast period 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Others), Product & Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening, Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect), Geography (Europe, North America, Asia-Pacific, South America, Middle East and Africa).

Some of the major factors contributing to the growth of the market:

  • Rising demands for novel small molecules, bio-therapeutic and cell based therapies
  • Increasing life sciences R&D expenditure
  • Increasing incidence of chronic diseases

Key Market Players:

The key market players for global cell based assays market are listed below:

  • GENERAL ELECTRIC
  • Danaher
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • ATCC
  • Aurelia Bioscience Ltd
  • BD
  • BioAgilytix Labs
  • BioVision Inc.
  • Cell Signaling Technology, Inc
  • Cisbio
  • Enzo Biochem Inc
  • Eurofins Scientific
  • LakePharma, Inc
  • Lonza
  • Miltenyi Biotec
  • XenoDiagnostics, LLC
Table of Contents

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. OVERVIEW OF GLOBAL CELL BASED ASSAYS MARKET
  • 1.4. LIMITATIONS
  • 1.5. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. MARKETS COVERED
  • 2.2. GLOBAL CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE
  • 2.3. YEARS CONSIDERED FOR THE STUDY
  • 2.4. CURRENCY AND PRICING
  • 2.5. DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7. DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS)
  • 2.8. DBMR MARKET POSITION GRID
  • 2.9. DBMR VENDOR SHARE ANALYSIS
  • 2.10. MULTIVARIATE MODELING
  • 2.11. PRODUCTS LIFELINE CURVE
  • 2.12. SECONDARY SOURCES
  • 2.13. ASSUMPTIONS

3. MARKET OVERVIEW

  • 3.1. DRIVERS
    • 3.1.1. INCREASING INCIDENCE OF CHRONIC DISEASES
    • 3.1.2. RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES
    • 3.1.3. INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE
  • 3.2. RESTRAINT
    • 3.2.1. STRINGENT REGULATORY REQUIREMENTS
    • 3.2.2. HIGH COST OF INSTRUMENTATION
  • 3.3. OPPORTUNITIES
    • 3.3.1. TECHNOLOGICAL ADVANCEMENTS
    • 3.3.2. STRATEGIC INITIATIVE BY THE MARKET PLAYERS
  • 3.4. CHALLENGES
    • 3.4.1. CHALLENGING ANALYSIS PROCEDURE

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL CELL-BASED ASSAYS MARKET, BY TYPE

  • 6.1. OVERVIEW
  • 6.2. CELL VIABILITY ASSAY
  • 6.3. CYTOTOXICITY ASSAY
  • 6.4. CELL PROLIFERATION ASSAY
  • 6.5. CELL DEATH ASSAY
  • 6.6. OTHERS

7. GLOBAL CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES

  • 7.1. OVERVIEW
  • 7.2. CONSUMABLES
    • 7.2.1. ASSAY KITS
    • 7.2.2. CELL LINES
      • 7.2.2.1. Primary Cell Lines
      • 7.2.2.2. Stem Cell Lines
      • 7.2.2.3. Immortalized Cell Lines
    • 7.2.3. REAGENTS
    • 7.2.4. MICROPLATES
  • 7.3. SERVICES
  • 7.4. INSTRUMENTS AND SOFTWARE

8. GLOBAL CELL-BASED ASSAYS MARKET, BY TECHNOLOGY

  • 8.1. OVERVIEW
  • 8.2. HIGH THROUGHPUT SCREENING
  • 8.3. FLOW CYTOMETRY
  • 8.4. HIGH CONTENT SCREENING
  • 8.5. LABEL FREE DETECTION

9. GLOBAL CELL-BASED ASSAYS MARKET, BY APPLICATION

  • 9.1. OVERVIEW
  • 9.2. DRUG DISCOVERY
    • 9.2.1. PREDICTIVE TOXICOLOGY
    • 9.2.2. PHARMACODYNAMIC STUDIES
    • 9.2.3. ADME RESEARCH
  • 9.3. BASIC RESEARCH
  • 9.4. OTHERS

10. GLOBAL CELL-BASED ASSAYS MARKET, BY END USER

  • 10.1. OVERVIEW
  • 10.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.3. CONTRACT RESEARCH ORGANIZATIONS
  • 10.4. ACADEMIC & RESEARCH INSTITUTIONS
  • 10.5. GOVERNMENT ORGANIZATIONS
  • 10.6. OTHERS

11. GLOBAL CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL

  • 11.1. OVERVIEW
  • 11.2. DIRECT
  • 11.3. INDIRECT

12. GLOBAL CELL BASED ASSAY MARKET, BY GEOGRAPHY

  • 12.1. OVERVIEW
  • 12.2. NORTH AMERICA
    • 12.2.1. U.S.
    • 12.2.2. CANADA
    • 12.2.3. MEXICO
  • 12.3. EUROPE
    • 12.3.1. GERMANY
    • 12.3.2. FRANCE
    • 12.3.3. UNITED KINGDOM
    • 12.3.4. ITALY
    • 12.3.5. SPAIN
    • 12.3.6. RUSSIA
    • 12.3.7. NETHERLANDS
    • 12.3.8. SWITZERLAND
    • 12.3.9. BEGIUM
    • 12.3.10. TURKEY
    • 12.3.11. REST OF EUROPE
  • 12.4. ASIA-PACIFIC
    • 12.4.1. CHINA
    • 12.4.2. JAPAN
    • 12.4.3. SOUTH KOREA
    • 12.4.4. INDIA
    • 12.4.5. SINGAPORE
    • 12.4.6. AUSTRALIA
    • 12.4.7. THAILAND
    • 12.4.8. MALAYSIA
    • 12.4.9. INDONESIA
    • 12.4.10. PHILIPPINES
    • 12.4.11. REST OF ASIA-PACIFIC
  • 12.5. SOUTH AMERICA
    • 12.5.1. BRAZIL
    • 12.5.2. REST OF SOUTH AMERICA
  • 12.6. MIDDLE EAST AND AFRICA
    • 12.6.1. SOUTH AFRICA
    • 12.6.2. REST OF MIDDLE EAST AND AFRICA

13. GLOBAL CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE

  • 13.1. COMPANY SHARE ANALYSIS: GLOBAL
  • 13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 13.3. COMPANY SHARE ANALYSIS: EUROPE
  • 13.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14. GLOBAL CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE

  • 14.1. COMPANY SHARE ANALYSIS: GLOBAL
  • 14.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 14.3. COMPANY SHARE ANALYSIS: EUROPE
  • 14.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

15. COMPANY PROFILE

  • 15.1. GENERAL ELECTRIC
    • 15.1.1. COMPANY SNAPSHOT
    • 15.1.2. REVENUE ANALYSIS
    • 15.1.3. COMPANY SHARE ANALYSIS
    • 15.1.4. PRODUCT PORTFOLIO
    • 15.1.5. RECENT DEVELOPMENTS
  • 15.2. DANAHER
    • 15.2.1. COMPANY SNAPSHOT
    • 15.2.2. REVENUE ANALYSIS
    • 15.2.3. COMPANY SHARE ANALYSIS
    • 15.2.4. PRODUCT PORTFOLIO
    • 15.2.5. RECENT DEVELOPMENT
  • 15.3. AGILENT TECHNOLOGIES, INC.
    • 15.3.1. 19.1 COMPANY SNAPSHOT
    • 15.3.2. REVENUE ANALYSIS
    • 15.3.3. COMPANY SHARE ANALYSIS
    • 15.3.4. PRODUCT PORTFOLIO
    • 15.3.5. RECENT DEVELOPMENTS
  • 15.4. THERMO FISHER SCIENTIFIC INC
    • 15.4.1. COMPANY SNAPSHOT
    • 15.4.2. REVENUE ANALYSIS
    • 15.4.3. COMPANY SHARE ANALYSIS
    • 15.4.4. PRODUCT PORTFOLIO
    • 15.4.5. RECENT DEVELOPMENT
  • 15.5. MERCK KGAA
    • 15.5.1. COMPANY SNAPSHOT
    • 15.5.2. REVENUE ANALYSIS
    • 15.5.3. PRODUCT PORTFOLIO
    • 15.5.4. RECENT DEVELOPMENT
  • 15.6. PERKINELMER INC, INC.
    • 15.6.1. COMPANY SNAPSHOT
    • 15.6.2. REVENUE ANALYSIS
    • 15.6.3. PRODUCT PORTFOLIO
    • 15.6.4. RECENT DEVELOPMENT
  • 15.7. BIO-RAD LABORATORIES, INC.
    • 15.7.1. COMPANY SNAPSHOT
    • 15.7.2. REVENUE ANALYSIS
    • 15.7.3. PRODUCT PORTFOLIO
    • 15.7.4. RECENT DEVELOPMENTS
  • 15.8. ATCC
    • 15.8.1. COMPANY SNAPSHOT
    • 15.8.2. PRODUCT PORTFOLIO
    • 15.8.3. RECENT DEVELOPMENT
  • 15.9. AURELIA BIOSCIENCE LTD.
    • 15.9.1. COMPANY SNAPSHOT
    • 15.9.2. SERVICE PORTFOLIO
    • 15.9.3. RECENT DEVELOPMENT
  • 15.10. BD
    • 15.10.1. COMPANY SNAPSHOT
    • 15.10.2. REVENUE ANALYSIS
    • 15.10.3. PRODUCT PORTFOLIO
    • 15.10.4. RECENT DEVELOPMENTS
  • 15.11. BIOAGILYTIX LABS
    • 15.11.1. COMPANY SNAPSHOT
    • 15.11.2. SERVICE PORTFOLIO
    • 15.11.3. RECENT DEVELOPMENTS

  • 15.12. BIOVISION INC.
    • 15.12.1. COMPANY SNAPSHOT
    • 15.12.2. PRODUCT PORTFOLIO
    • 15.12.3. RECENT DEVELOPMENT
  • 15.13. CELL SIGNALING TECHNOLOGY, INC.
    • 15.13.1. COMPANY SNAPSHOT
    • 15.13.2. PRODUCT PORTFOLIO
    • 15.13.3. RECENT DEVELOPMENT
  • 15.14. CISBIO
    • 15.14.1. COMPANY SNAPSHOT
    • 15.14.2. PRODUCT PORTFOLIO
    • 15.14.3. RECENT DEVELOPMENT
  • 15.15. ENZO BIOCHEM INC.
    • 15.15.1. COMPANY SNAPSHOT
    • 15.15.2. REVENUE ANALYSIS
    • 15.15.3. PRODUCT PORTFOLIO
    • 15.15.4. RECENT DEVELOPMENT
  • 15.16. EUROFINS SCIENTIFIC
    • 15.16.1. COMPANY SNAPSHOT
    • 15.16.2. REVENUE ANALYSIS
    • 15.16.3. PRODUCT AND SERVICE PORTFOLIO
    • 15.16.4. RECENT DEVELOPMENTS
  • 15.17. LAKEPHARMA, INC.
    • 15.17.1. COMPANY SNAPSHOT
    • 15.17.2. SERVICE PORTFOLIO
    • 15.17.3. RECENT DEVELOPMENT
  • 15.18. LONZA
    • 15.18.1. COMPANY SNAPSHOT
    • 15.18.2. REVENUE ANALYSIS
    • 15.18.3. SERVICE PORTFOLIO
    • 15.18.4. RECENT DEVELOPMENT
  • 15.19. MILTENYI BIOTEC
    • 15.19.1. COMPANY SNAPSHOT
    • 15.19.2. 15.2 PRODUCT PORTFOLIO
    • 15.19.3. RECENT DEVELOPMENT
  • 15.20. XENO DIAGNOSTICS, LLC.
    • 15.20.1. COMPANY SNAPSHOT
    • 15.20.2. PRODUCT PORTFOLIO
    • 15.20.3. RECENT DEVELOPMENT

16. QUESTIONNAIRE

17. RELATED REPORTS

LIST OF TABLES

  • TABLE 1 AGEING WORLD POPULATION (IN MILLIONS)
  • TABLE 2 TABLE REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS)
  • TABLE 3 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
  • TABLE 4 GLOBAL CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 5 GLOBAL CELL VIABILITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6 GLOBAL CYTOTOXICITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 GLOBAL CELL PROLIFERATION ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 GLOBAL CELL DEATH ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 GLOBAL OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 GLOBAL CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 11 GLOBAL CONSUMABLES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 GLOBAL CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 13 GLOBAL CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 14 GLOBAL SERVICES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 GLOBAL INSTRUMENTS AND SOFTWARE IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 GLOBAL CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 17 GLOBAL HIGH THROUGHPUT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 GLOBAL FLOW CYTOMETRY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 GLOBAL HIGH CONTENT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20 GLOBAL LABEL FREE DETECTION IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 GLOBAL CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 22 GLOBAL DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23 GLOBAL DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 24 GLOBAL BASIC RESEARCH IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25 GLOBAL OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 GLOBAL CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 27 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 28 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 GLOBAL ACADEMIC & RESEARCH INSTITUTIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 30 GLOBAL GOVERNMENT ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 GLOBAL OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32 GLOBAL CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 33 GLOBAL DIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 34 GLOBAL INDIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 35 GLOBAL CELL BASED ASSAY MARKET, BY GEOGRAPHY, 2017-2026 (USD MILLION)
  • TABLE 36 NORTH AMERICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 37 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 38 NORTH AMERICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 39 NORTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 40 NORTH AMERICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 41 NORTH AMERICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 42 NORTH AMERICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 43 NORTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 44 NORTH AMERICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 45 NORTH AMERICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 46 U.S. CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 47 U.S. CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 48 U.S. CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 49 U.S. CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 50 U.S. CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 51 U.S. CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 52 U.S. DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 53 U.S. CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 54 U.S CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 55 CANADA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 56 CANADA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 57 CANADA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 58 CANADA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 59 CANADA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 60 CANADA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 61 CANADA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 62 CANADA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 63 CANADA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 64 MEXICO CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 65 MEXICO CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 66 MEXICO CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 67 MEXICO CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 68 MEXICO CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 69 MEXICO CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 70 MEXICO DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 71 MEXICO CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 72 MEXICO CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 73 EUROPE CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 74 EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 75 EUROPE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 76 EUROPE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 77 EUROPE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 78 EUROPE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 79 EUROPE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 80 EUROPE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 81 EUROPE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 82 EUROPE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 83 GERMANY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 84 GERMANY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 85 GERMANY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 86 GERMANY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 87 GERMANY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 88 GERMANY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 89 GERMANY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 90 GERMANY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 91 FRANCE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 92 FRANCE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 93 FRANCE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 94 FRANCE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 95 FRANCE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 96 FRANCE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 97 FRANCE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 98 FRANCE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 99 FRANCE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 100 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 101 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 102 UNITED KINGDOM CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 103 UNITED KINGDOM CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 104 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 105 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 106 UNITED KINGDOM DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 107 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 108 UNITED KINGDOM CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 109 ITALY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 110 ITALY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 111 ITALY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 112 ITALY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 113 ITALY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 114 ITALY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 115 ITALY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 116 ITALY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 117 ITALY CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 118 SPAIN CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 119 SPAIN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 120 SPAIN CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 121 SPAIN CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 122 SPAIN CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 123 SPAIN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 124 SPAIN DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 125 SPAIN CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 126 SPAIN CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 127 RUSSIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 128 RUSSIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 129 RUSSIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 130 RUSSIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 131 RUSSIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 132 RUSSIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 133 RUSSIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 134 RUSSIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 135 RUSSIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 136 NETHERLANDS CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 137 NETHERLANDS CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 138 NETHERLANDS CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 139 NETHERLANDS CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 140 NETHERLANDS CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 141 NETHERLANDS CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 142 NETHERLANDS DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 143 NETHERLANDS CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 144 NETHERLANDS CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 145 SWITZERLAND CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 146 SWITZERLAND CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 147 SWITZERLAND CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 148 SWITZERLAND CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 149 SWITZERLAND CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 150 SWITZERLAND CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 151 SWITZERLAND DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 152 SWITZERLAND CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 153 SWITZERLAND CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 154 BELGIUM CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 155 BELGIUM CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 156 BELGIUM CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 157 BELGIUM CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 158 BELGIUM CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 159 BELGIUM CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 160 BELGIUM DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 161 BELGIUM CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 162 BELGIUM CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 163 TURKEY CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 164 TURKEY CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 165 TURKEY CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 166 TURKEY CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 167 TURKEY CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 168 TURKEY CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 169 TURKEY DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 170 TURKEY CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 171 TURKEY CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 172 REST OF EUROPE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 173 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 174 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 175 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 176 ASIA-PACIFIC CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 177 ASIA-PACIFIC CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 178 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 179 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 180 ASIA-PACIFIC DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 181 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 182 ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 183 CHINA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 184 CHINA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 185 CHINA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 186 CHINA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 187 CHINA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 188 CHINA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 189 CHINA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 190 CHINA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 191 CHINA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 192 JAPAN CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 193 JAPAN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 194 JAPAN CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 195 JAPAN CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 196 JAPAN CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 197 JAPAN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 198 JAPAN DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 199 JAPAN CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 200 JAPAN CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 201 SOUTH KOREA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 202 SOUTH KOREA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 203 SOUTH KOREA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 204 SOUTH KOREA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 205 SOUTH KOREA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 206 SOUTH KOREA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 207 SOUTH KOREA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 208 SOUTH KOREA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 209 SOUTH KOREA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 210 INDIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 211 INDIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 212 INDIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 213 INDIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 214 INDIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 215 INDIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 216 INDIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 217 INDIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 218 INDIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 219 SINGAPORE CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 220 SINGAPORE CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 221 SINGAPORE CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 222 SINGAPORE CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 223 SINGAPORE CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 224 SINGAPORE CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 225 SINGAPORE DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 226 SINGAPORE CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 227 SINGAPORE CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 228 AUSTRALIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 229 AUSTRALIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 230 AUSTRALIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 231 AUSTRALIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 232 AUSTRALIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 233 AUSTRALIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 234 AUSTRALIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 235 AUSTRALIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 236 AUSTRALIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 237 THAILAND CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 238 THAILAND CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 239 THAILAND CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 240 THAILAND CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 241 THAILAND CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 242 THAILAND CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 243 THAILAND DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 244 THAILAND CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 245 THAILAND CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 246 MALAYSIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 247 MALAYSIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 248 MALAYSIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 249 MALAYSIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 250 MALAYSIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 251 MALAYSIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 252 MALAYSIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 253 MALAYSIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 254 MALAYSIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 255 INDONESIA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 256 INDONESIA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 257 INDONESIA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 258 INDONESIA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 259 INDONESIA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 260 INDONESIA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 261 INDONESIA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 262 INDONESIA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 263 INDONESIA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 264 PHILIPPINES CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 265 PHILIPPINES CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 266 PHILIPPINES CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 267 PHILIPPINES CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 268 PHILIPPINES CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 269 PHILIPPINES CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 270 PHILIPPINES DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 271 PHILIPPINES CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 272 PHILIPPINES CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 273 REST OF ASIA-PACIFIC CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 274 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 275 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 276 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 277 SOUTH AMERICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 278 SOUTH AMERICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 279 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 280 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 281 SOUTH AMERICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 282 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 283 SOUTH AMERICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 284 BRAZIL CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 285 BRAZIL CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 286 BRAZIL CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 287 BRAZIL CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 288 BRAZIL CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 289 BRAZIL CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 290 BRAZIL DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 291 BRAZIL CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 292 BRAZIL CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 293 REST OF SOUTH AMERICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 294 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 295 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 296 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 297 MIDDLE EAST AND AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 298 MIDDLE EAST AND AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 299 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 300 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 301 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 302 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 303 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 304 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 305 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 306 SOUTH AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 307 SOUTH AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 308 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 309 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 310 SOUTH AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 311 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 312 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 313 REST OF MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL CELL BASED ASSAYS MARKET
  • FIGURE 2 GLOBAL CELL BASED ASSAYS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 GLOBAL CELL BASED ASSAYS MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL CELL BASED ASSAYS MARKET: GLOBAL VS REGIONAL ANALYSIS
  • FIGURE 5 GLOBAL CELL BASED ASSAYS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL CELL BASED ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID (ON THE BASIS OF SERVICES)
  • FIGURE 9 GLOBAL CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF PRODUCTS)
  • FIGURE 10 GLOBAL CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF SERVICES)
  • FIGURE 11 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF THE GLOBAL CELL BASED ASSAYS MARKET
  • FIGURE 12 WORLDWIDE BIOPHARMA COMPANIES R&D EXPENDITURE (IN MILLION U.S. DOLLARS)
  • FIGURE 13 GLOBAL CELL BASED ASSAYS MARKET: SEGMENTATION
  • FIGURE 14 INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES ARE EXPECTED TO DRIVE THE GLOBAL CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 15 CELL VIABILITY ASSAY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 16 ASIA-PACIFIC IS THE MAXIMUM GROWING AND NORTH AMERICA IS THE MOST PROFITABLE REVENUE POCKETS FOR GLOBAL CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 17 GLOBAL CELL BASED ASSAYS MARKET DOMINATED BY CELL VIABILITY ASSAY (2018)
  • FIGURE 18 GLOBAL CELL BASED ASSAYS MARKET: BY TYPE, 2018
  • FIGURE 19 GLOBAL CELL BASED ASSAYS MARKET: BY TYPE, CAGR (2019-2026)
  • FIGURE 20 GLOBAL CELL BASED ASSAYS MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 21 GLOBAL CELL BASED ASSAYS MARKET DOMINATED BY CONSUMABLES (2018)
  • FIGURE 22 GLOBAL CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, 2018
  • FIGURE 23 GLOBAL CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, CAGR (2019-2026)
  • FIGURE 24 GLOBAL CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
  • FIGURE 25 GLOBAL CELL BASED ASSAYS MARKET DOMINATED BY HIGH THROUGHPUT SCREENING (2018)
  • FIGURE 26 GLOBAL CELL BASED ASSAYS MARKET: BY TECHNOLOGY, 2018
  • FIGURE 27 GLOBAL CELL BASED ASSAYS MARKET: BY TECHNOLOGY, CAGR (2019-2026)
  • FIGURE 28 GLOBAL CELL BASED ASSAYS MARKET: BY TECHNOLOGY, LIFELINE CURVE
  • FIGURE 29 GLOBAL CELL BASED ASSAYS MARKET DOMINATED BY DRUG DISCOVERY (2018)
  • FIGURE 30 GLOBAL CELL BASED ASSAYS MARKET: BY APPLICATION, 2018
  • FIGURE 31 GLOBAL CELL BASED ASSAYS MARKET: BY APPLICATION, CAGR (2019-2026)
  • FIGURE 32 GLOBAL CELL BASED ASSAYS MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 33 GLOBAL CELL BASED ASSAYS MARKET DOMINATED BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (2018)
  • FIGURE 34 GLOBAL CELL BASED ASSAYS MARKET: BY END USER, 2018
  • FIGURE 35 GLOBAL CELL BASED ASSAYS MARKET: BY END USER, CAGR (2019-2026)
  • FIGURE 36 GLOBAL CELL BASED ASSAYS MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 37 GLOBAL CELL BASED ASSAYS MARKET DOMINATED BY DIRECT (2018)
  • FIGURE 38 GLOBAL CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, 2018
  • FIGURE 39 GLOBAL CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2019-2026)
  • FIGURE 40 GLOBAL CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 41 GLOBAL CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 42 GLOBAL CELL BASED ASSAY MARKET: BY GEOGRAPHY (2018)
  • FIGURE 43 GLOBAL CELL BASED ASSAY MARKET: BY GEOGRAPHY (2019 & 2026)
  • FIGURE 44 GLOBAL CELL BASED ASSAY MARKET: BY GEOGRAPHY (2018 & 2026)
  • FIGURE 45 GLOBAL CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 1 NORTH AMERICA CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 2 NORTH AMERICA CELL BASED ASSAY MARKET: BY COUNTRY (2018)
  • FIGURE 3 NORTH AMERICA CELL BASED ASSAY MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 4 NORTH AMERICA CELL BASED ASSAY MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 5 NORTH AMERICA CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 6 EUROPE CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 7 EUROPE CELL BASED ASSAY MARKET: BY COUNTRY (2018)
  • FIGURE 8 EUROPE CELL BASED ASSAY MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 9 EUROPE CELL BASED ASSAY MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 10 EUROPE CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 11 ASIA-PACIFIC CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 12 ASIA-PACIFIC CELL BASED ASSAY MARKET: BY COUNTRY (2018)
  • FIGURE 13 ASIA-PACIFIC CELL BASED ASSAY MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 14 ASIA-PACIFIC CELL BASED ASSAY MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 15 ASIA-PACIFIC CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 16 SOUTH AMERICA CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 17 SOUTH AMERICA CELL BASED ASSAY MARKET: BY COUNTRY (2018)
  • FIGURE 18 SOUTH AMERICA CELL BASED ASSAY MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 19 SOUTH AMERICA CELL BASED ASSAY MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 20 SOUTH AMERICA CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 21 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 22 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: BY COUNTRY (2018)
  • FIGURE 23 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 24 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 25 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 26 GLOBAL CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 27 NORTH AMERICA CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 28 EUROPE CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 29 ASIA-PACIFIC CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 30 GLOBAL CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 31 NORTH AMERICA CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 32 EUROPE CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 33 ASIA-PACIFIC CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
Back to Top